Detalhe da pesquisa
1.
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood
; 143(16): 1616-1627, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215395
2.
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group report.
Blood
; 141(15): 1802-1811, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603187
3.
Genomic landscape of Down syndrome-associated acute lymphoblastic leukemia.
Blood
; 142(2): 172-184, 2023 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37001051
4.
The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.
Blood
; 142(8): 711-723, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216686
5.
The genetic basis and cell of origin of mixed phenotype acute leukaemia.
Nature
; 562(7727): 373-379, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30209392
6.
Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.
Cancer
; 129(15): 2308-2320, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37078412
7.
The impact of increasing karyotypic complexity and evolution on survival in patients with CLL treated with ibrutinib.
Blood
; 138(23): 2372-2382, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314481
8.
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results.
Hematol Oncol
; 41(4): 771-775, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37010242
9.
Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Pediatr Blood Cancer
; : e30467, 2023 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37259259
10.
Sex-based disparities in outcome in pediatric acute lymphoblastic leukemia: a Children's Oncology Group report.
Cancer
; 128(9): 1863-1870, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201611
11.
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
N Engl J Med
; 379(26): 2517-2528, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501481
12.
Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Blood
; 134(15): 1227-1237, 2019 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350265
13.
Prognostic significance of translocations in the presence of mutated IGHV and of cytogenetic complexity at diagnosis of chronic lymphocytic leukemia.
Haematologica
; 106(6): 1608-1615, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32414849
14.
Prognostic impact of minimal residual disease at the end of consolidation in NCI standard-risk B-lymphoblastic leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(4): e28929, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33559396
15.
Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
Cancer
; 126(3): 593-601, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31661160
16.
Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing.
Bioinformatics
; 35(17): 2924-2931, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689715
17.
CytoGPS: a web-enabled karyotype analysis tool for cytogenetics.
Bioinformatics
; 35(24): 5365-5366, 2019 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263896
18.
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Blood
; 131(17): 1910-1919, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29437592
19.
Phase 1b study of obinutuzumab, ibrutinib, and venetoclax in relapsed and refractory chronic lymphocytic leukemia.
Blood
; 132(15): 1568-1572, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30111609
20.
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood
; 132(8): 815-824, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29997224